Table of Contents:

1 Report Prologue
2 Introduction
2.1 Market Definition
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 Research Methodology
3.1.1 Primary Research Methodology
3.1.2 Secondary Research Methodology
3.1.3 Market Share Analysis
3.1.4 Market Pricing Approach
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Prevalence of Ophthalmological Disorders
4.2.2 Favorable Government Funding
4.2.3 Product Advancements
4.3 Restraints
4.3.1 Lack of Awareness
4.3.2 Longer Duration of Treatment
4.4 Opportunity
4.4.1 Entering untapped markets
4.5 Mega Trend
4.5.1 Technological Trends
4.6 Macroeconomics
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-sales Monitoring
5.2 Porter's Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
5.5 Demand & Supply: Gap Analysis
6 Global Amblyopia Market By Type
6.1 Introduction
6.1.1 Strabismus Amblyopia
6.1.2 Refractive Amblyopia
6.1.3 Deprivation Amblyopia
6.1.4 Reverse Amblyopia
7 Global Amblyopia Market By Diagnosis
7.1 Introduction
7.1.1 Visual acuity tests
7.1.2 Photo screening
7.1.3 Bruckner test
8 Global Amblyopia Market By Treatment
8.1 Introduction
8.1.1 Eye Patches
8.1.2 Atropine Drops
8.1.3 Glasses
8.1.4 Video game
9 Global Amblyopia Market By End User
9.1 Introduction
9.1.1 Hospitals & Pharmacies
9.1.2 Ophthalmic Clinics
10 Global Amblyopia Market By Region
10.1 Americas
10.1.1 North America
10.1.1.1 U.S.
10.1.1.2 Canada
10.1.2 South America
10.2 Europe
10.2.1 Western Europe
10.2.1.1 Germany
10.2.1.2 France
10.2.1.3 UK
10.2.1.4 Italy
10.2.1.5 Spain
10.2.1.6 Rest of Western Europe
10.2.2 Eastern Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 Republic of Korea
10.3.6 Rest of Asia Pacific
10.4 Middle East & Africa
10.4.1 Middle East
10.4.2 Africa
11 Company Landscape
11.1 Key Player Analysis, by Product
11.1.1 Patches
11.1.2 Video Games
11.1.3 Glasses
11.2 Key Growth Strategy Analysis
11.3 Recent key developments
12 Company Profile
12.1 Amblyoptica (Holding) Pty Ltd
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Products
12.1.4 Strategy
12.1.5 Key Developments
12.2 Amblyotech, Inc.
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Products
12.2.4 Strategy
12.2.5 Key Developments
12.3 Good-Lite Co
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Products
12.3.4 Strategy
12.3.5 Key Developments
12.4 Vivid Vision, Inc.
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Products
12.4.4 Strategy
12.4.5 Key Developments
12.5 CooperVision
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Products
12.5.4 Strategy
12.5.5 Key Developments
12.6 Johnson & Johnson
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Products
12.6.4 Strategy
12.6.5 Key Developments
12.7 Novartis AG.
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Products
12.7.4 Strategy
12.7.5 Key Developments
12.8 Carl Zeiss AG
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Products
12.8.4 Strategy
12.8.5 Key Developments
12.9 HOYA Corporation
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Products
12.9.4 Strategy
12.9.5 Key Developments
12.1 Krafty Eye Patches.
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Products
12.10.4 Strategy
12.10.5 Key Developments
12.11 Fresnel Prism and Lens Co.
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Products
12.11.4 Strategy
12.11.5 Key Developments
12.12 Hilco Vision
12.12.1 Company Overview
12.12.2 Financials
12.12.3 Products
12.12.4 Strategy
12.12.5 Key Developments
12.13 McKesson Corporation
12.13.1 Company Overview
12.13.2 Financials
12.13.3 Products
12.13.4 Strategy
12.13.5 Key Developments
13 Conclusion
13.1 Key Findings
13.1.1 The CEO's Viewpoint
13.1.2 Unmet Needs
13.1.3 Key Companies to Watch
13.1.4 Prediction of Amblyopia Industry
14 Appendix
14.1 Discussion Blue Print
14.2 References